Shree Rama Multi-Tech Limited
SHREERAMA.NS News Today: Stay Updated with the Latest Shree Rama Multi-Tech Limited News in Real Time
Find SHREERAMA.NS news now at Meyka AI. Stay informed with the latest Shree Rama Multi-Tech Limited stocks updates, including price news, market analysis, and expert insights.

TEM.AX stock trades at A$0.006 in pre-market April 2026
TEM.AX stock price at A$0.006 on ASX. Tempest Minerals Limited mineral exploration company analysis and trading data.

WB2.DE Westinghouse Air Brake Beats EPS Estimate
Westinghouse Air Brake Technologies (WB2.DE) beat EPS estimate at $2.35 vs $2.17, but missed revenue at $2.55B vs $2.56B estimate.

5277.T Stock Bounces at ¥452 on April 24 Pre-Market
Spancrete Corporation (5277.T) trades at ¥452 pre-market on JPX with a B grade from Meyka AI. Construction materials firm shows mixed signals.

0022.HK Mexan Limited Drops 20% in Pre-Market Trading on HKSE
Mexan Limited (0022.HK) falls 20% to HK$0.076 in pre-market session. Travel lodging stock faces pressure amid weak technical signals.

Lotte Arai Resort Forest Violation April 24: Illegal Logging Sparks Regulatory Action
Lotte Arai Resort faces Forest Law violation for unauthorized 2-hectare logging. Niigata Prefecture issues administrative guidance. Environmental…

BANDHANBNK.NS Stock Falls 1.27% on Apr 23 as Earnings Loom
BANDHANBNK.NS stock declined 1.27% to INR 173.90 on NSE. Earnings announcement scheduled for April 28. PE ratio at 28.24.

Lufthansa Cuts 20,000 Flights April 23: Fuel Crisis Deepens
Lufthansa cancels 20,000 flights by October 2026 due to soaring fuel costs, reducing summer capacity by 1% amid Iran conflict-driven energy crisis.

0679.HK surges 41.9% as Asia Tele-Net gains momentum on HKSE
0679.HK stock jumps 41.9% to HK$9.82 on HKSE. Asia Tele-Net gains momentum with strong trading volume and technical strength signals.

IMM.AX Stock Surges 1.37% on ASCO Presentation News, 24 Apr 2026
IMM.AX stock rises 1.37% to A$0.074 on ASCO conference presentation announcement. Immutep Limited gains pre-market momentum on clinical trial updates.